Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dwaipayan Mukherjee

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cancer Chemotherapy and Pharmacology|January 5, 2021
Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug-drug interaction predictions using a PBPK approachSumit Bhatnagar, Dwaipayan Mukherjee, Ahmed Hamed Salem, et al.
Journal of Clinical Pharmacology|August 23, 2022
Impact of Multiple Concomitant CYP3A Inhibitors on Venetoclax Pharmacokinetics: A PBPK and Population PK-Informed AnalysisDwaipayan Mukherjee, Deanna J Brackman, Ahmed A Suleiman, et al.
Nanomaterials (Basel, Switzerland)|August 5, 2015
Modeling <i>In Vivo</i> Interactions of Engineered Nanoparticles in the Pulmonary Alveolar Lining FluidDwaipayan Mukherjee, Alexandra Porter, Mary Ryan, et al.
Infectious Diseases and Therapy|July 20, 2023
Assessment of Drug-Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and SimulationsDwaipayan Mukherjee, Michelle Collins, Douglas E Dylla, et al.
Plos One|December 5, 2014
Physiologically-based toxicokinetic modeling of zearalenone and its metabolites: application to the Jersey girl studyDwaipayan Mukherjee, Steven G Royce, Jocelyn A Alexander, et al.
Clinical Pharmacology and Therapeutics|May 13, 2022
Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC PerspectiveXiaoyan Chu, Bhagwat Prasad, Sibylle Neuhoff, et al.
Journal of Nanoparticle Research : an Interdisciplinary Forum for Nanoscale Science and Technology|January 20, 2015
Modeling physicochemical interactions affecting in vitro cellular dosimetry of engineered nanomaterials: application to nanosilverDwaipayan Mukherjee, Bey Fen Leo, Steven G Royce, et al.
American Journal of Respiratory and Critical Care Medicine|January 21, 2025
Location of Care Delivery for Pulmonary Arterial Hypertension in the United StatesPeter J Leary, Rachel J Le, Sumeet Panjabi, et al.
Journal of Toxicology|December 27, 2014
Modeling in vitro cellular responses to silver nanoparticlesDwaipayan Mukherjee, Steven G Royce, Srijata Sarkar, et al.
Journal of Nanoparticle Research : an Interdisciplinary Forum for Nanoscale Science and Technology|March 7, 2015
Modeling Population Exposures to Silver Nanoparticles Present in Consumer ProductsSteven G Royce, Dwaipayan Mukherjee, Ting Cai, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|January 5, 2021
Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug-drug interaction predictions using a PBPK approachSumit Bhatnagar, Dwaipayan Mukherjee, Ahmed Hamed Salem, et al.
Journal of Clinical Pharmacology|August 23, 2022
Impact of Multiple Concomitant CYP3A Inhibitors on Venetoclax Pharmacokinetics: A PBPK and Population PK-Informed AnalysisDwaipayan Mukherjee, Deanna J Brackman, Ahmed A Suleiman, et al.
Nanomaterials (Basel, Switzerland)|August 5, 2015
Modeling <i>In Vivo</i> Interactions of Engineered Nanoparticles in the Pulmonary Alveolar Lining FluidDwaipayan Mukherjee, Alexandra Porter, Mary Ryan, et al.
Infectious Diseases and Therapy|July 20, 2023
Assessment of Drug-Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and SimulationsDwaipayan Mukherjee, Michelle Collins, Douglas E Dylla, et al.
Plos One|December 5, 2014
Physiologically-based toxicokinetic modeling of zearalenone and its metabolites: application to the Jersey girl studyDwaipayan Mukherjee, Steven G Royce, Jocelyn A Alexander, et al.
Clinical Pharmacology and Therapeutics|May 13, 2022
Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC PerspectiveXiaoyan Chu, Bhagwat Prasad, Sibylle Neuhoff, et al.
Journal of Nanoparticle Research : an Interdisciplinary Forum for Nanoscale Science and Technology|January 20, 2015
Modeling physicochemical interactions affecting in vitro cellular dosimetry of engineered nanomaterials: application to nanosilverDwaipayan Mukherjee, Bey Fen Leo, Steven G Royce, et al.
American Journal of Respiratory and Critical Care Medicine|January 21, 2025
Location of Care Delivery for Pulmonary Arterial Hypertension in the United StatesPeter J Leary, Rachel J Le, Sumeet Panjabi, et al.
Journal of Toxicology|December 27, 2014
Modeling in vitro cellular responses to silver nanoparticlesDwaipayan Mukherjee, Steven G Royce, Srijata Sarkar, et al.
Journal of Nanoparticle Research : an Interdisciplinary Forum for Nanoscale Science and Technology|March 7, 2015
Modeling Population Exposures to Silver Nanoparticles Present in Consumer ProductsSteven G Royce, Dwaipayan Mukherjee, Ting Cai, et al.
Pageof 3